Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BioLineRx PE Ratio 2012-2025 | BLRX

Current and historical p/e ratio for BioLineRx (BLRX) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. BioLineRx PE ratio as of July 15, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
BioLineRx PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-15 4.52 0.00
2025-03-31 2.96 $-1.01 0.00
2024-12-31 8.56 $-2.80 0.00
2024-09-30 21.44 $-8.80 0.00
2024-06-30 22.80 $-18.00 0.00
2024-03-31 44.80 $-30.40 0.00
2023-12-31 62.80 $-36.00 0.00
2023-09-30 72.80 $-33.60 0.00
2023-06-30 63.80 $-27.60 0.00
2023-03-31 35.46 $-22.00 0.00
2022-12-31 23.60 $-20.00 0.00
2022-09-30 37.00 $-19.60 0.00
2022-06-30 51.20 $-22.80 0.00
2022-03-31 68.40 $-22.40 0.00
2021-12-31 81.60 $-29.20 0.00
2021-09-30 110.00 $-50.40 0.00
2021-06-30 112.40 $-53.20 0.00
2021-03-31 111.60 $-65.20 0.00
2020-12-31 100.80 $-78.40 0.00
2020-09-30 65.60 $-92.80 0.00
2020-06-30 68.40 $-96.80 0.00
2020-03-31 53.20 $-80.40 0.00
2019-12-31 90.00 $-86.39 0.00
2019-09-30 105.60 $-77.57 0.00
2019-06-30 219.00 $-97.55 0.00
2019-03-31 258.00 $-125.94 0.00
2018-12-31 262.38 $-131.93 0.00
2018-09-30 642.00 $-143.93 0.00
2018-06-30 534.00 $-149.93 0.00
2018-03-31 522.00 $-149.93 0.00
2017-12-31 654.00 $-161.92 0.00
2017-09-30 672.00 $-197.90 0.00
2017-06-30 507.00 $-203.90 0.00
2017-03-31 576.30 $-215.89 0.00
2016-12-31 552.00 $-227.89 0.00
2016-09-30 690.00 $-191.90 0.00
2016-06-30 480.00 $-161.92 0.00
2016-03-31 612.00 $-173.91 0.00
2015-12-31 780.00 $-161.92 0.00
2015-09-30 918.00 $-185.91 0.00
2015-06-30 1596.00 $-179.91 0.00
2015-03-31 1266.00 $-197.90 0.00
2014-12-31 972.00 $-209.90 0.00
2014-09-30 924.00 $-263.87 0.00
2014-06-30 1248.00 $-371.81 0.00
2014-03-31 1338.00 $-419.79 0.00
2013-12-31 1686.00 $-479.76 0.00
2013-09-30 1314.00 $-539.73 0.00
2013-06-30 972.00 $-659.67 0.00
2013-03-31 1008.00 $-551.72 0.00
2012-12-31 1518.00 $-611.69 0.00
2012-09-30 1578.00 $-611.69 0.00
2012-06-30 1464.00 $-491.75 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.019B $0.029B
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.266B 28.24
Zoetis (ZTS) United States $68.055B 25.39
Takeda Pharmaceutical (TAK) Japan $46.933B 9.34
Daiichi Sankyo, - (DSNKY) Japan $43.096B 22.09
BeOne Medicines - (ONC) Cayman Islands $29.559B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.954B 0.00
Summit Therapeutics (SMMT) United States $18.091B 0.00
Merck (MKKGY) Germany $16.498B 12.09
Shionogi (SGIOY) Japan $14.172B 14.20
United Therapeutics (UTHR) United States $13.227B 11.70
Neurocrine Biosciences (NBIX) United States $12.988B 44.49
Orion OYJ (ORINY) Finland $10.973B 29.68
IPSEN (IPSEY) France $10.239B 0.00
Stevanato Group S.p.A (STVN) Italy $7.753B 47.41
Corcept Therapeutics (CORT) United States $7.573B 61.56
Madrigal Pharmaceuticals (MDGL) United States $6.908B 0.00
Grifols, S.A (GRFS) Spain $6.717B 0.00
Ionis Pharmaceuticals (IONS) United States $6.685B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.265B 16.01
Soleno Therapeutics (SLNO) United States $4.212B 0.00
Hypermarcas (HYPMY) Brazil $3.167B 20.83
Crinetics Pharmaceuticals (CRNX) United States $2.980B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.592B 14.02
Catalyst Pharmaceuticals (CPRX) United States $2.555B 8.95
NewAmsterdam Pharma (NAMS) Netherlands $2.360B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.014B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.825B 0.00
Ocular Therapeutix (OCUL) United States $1.767B 0.00
ARS Pharmaceuticals (SPRY) United States $1.725B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
Guardian Pharmacy Services (GRDN) United States $1.301B 0.00
Harrow (HROW) United States $1.261B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.215B 24.30
Ardelyx (ARDX) United States $1.077B 0.00
Enliven Therapeutics (ELVN) United States $1.062B 0.00
Collegium Pharmaceutical (COLL) United States $1.028B 5.55
Akebia Therapeutics (AKBA) United States $1.019B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.004B 0.00
ProKidney (PROK) United States $0.986B 0.00
Verve Therapeutics (VERV) United States $0.982B 0.00
Dyne Therapeutics (DYN) United States $0.941B 0.00
Xeris Biopharma Holdings (XERS) United States $0.827B 0.00
Cronos Group (CRON) Canada $0.779B 0.00
KalVista Pharmaceuticals (KALV) United States $0.758B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.724B 0.00
Zevra Therapeutics (ZVRA) United States $0.699B 0.00
Xencor (XNCR) United States $0.601B 0.00
Relay Therapeutics (RLAY) United States $0.600B 0.00
USANA Health Sciences (USNA) United States $0.583B 12.68
Theravance Biopharma (TBPH) United States $0.577B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
Bioventus (BVS) United States $0.542B 13.75
Oruka Therapeutics (ORKA) United States $0.534B 0.00
Organogenesis (ORGO) United States $0.511B 0.00
Siga Technologies (SIGA) United States $0.479B 10.00
Tourmaline Bio (TRML) United States $0.477B 0.00
Aquestive Therapeutics (AQST) United States $0.399B 0.00
Savara (SVRA) United States $0.396B 0.00
Altimmune (ALT) United States $0.339B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.13
Tonix Pharmaceuticals Holding (TNXP) United States $0.325B 0.00
Heron Therapeutics (HRTX) United States $0.311B 0.00
AleAnna (ANNA) United States $0.305B 0.00
Aldeyra Therapeutics (ALDX) United States $0.298B 0.00
Nektar Therapeutics (NKTR) United States $0.295B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 25.34
Nanobiotix S.A (NBTX) France $0.251B 0.00
OmniAb (OABI) United States $0.238B 0.00
Esperion Therapeutics (ESPR) United States $0.224B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.202B 0.00
China SXT Pharmaceuticals (SXTC) China $0.194B 0.00
4D Molecular Therapeutics (FDMT) United States $0.193B 0.00
Galectin Therapeutics (GALT) United States $0.177B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
Journey Medical (DERM) United States $0.163B 0.00
Liminatus Pharma (LIMN) United States $0.145B 0.00
Avita Medical (RCEL) United States $0.141B 0.00
Lexeo Therapeutics (LXEO) United States $0.137B 0.00
Lyell Immunopharma (LYEL) United States $0.135B 0.00
Inhibikase Therapeutics (IKT) United States $0.134B 0.00
Korro Bio (KRRO) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.111B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.73
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.099B 0.00
Jupiter Neurosciences (JUNS) United States $0.098B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Nutriband (NTRB) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Metagenomi (MGX) United States $0.078B 0.00
Rafael Holdings (RFL) United States $0.077B 0.00
Dominari Holdings (DOMH) United States $0.076B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.074B 0.00
Fractyl Health (GUTS) United States $0.073B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.066B 0.00
Inotiv (NOTV) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Klotho Neurosciences (KLTO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
Wellgistics Health (WGRX) United States $0.058B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.052B 38.89
Avalo Therapeutics (AVTX) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Vivos Therapeutics (VVOS) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
FibroGen (FGEN) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
BioVie (BIVI) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.21
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Incannex Healthcare (IXHL) Australia $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 8.99
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00